Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology to provide personalized insight into the therapy response. By combining proven approaches to measuring DNA with cutting-edge technology to improve accuracy and sensitivity Cadex Genomics provides unique insight into therapy response using simple blood draws.
Alibrex is a blood-based assay, developed to help physicians identify patients who are not responding to drug therapy. The test is optimized to maximize NPV, that is, minimize the number of false non-responders.
|
|
|
1-10 employees
View all Cadex Genomics employees
|
|
Biotechnology
|
|
4340 Duncan Avenue, Suite 256, St. Louis, MO 63011, US
|
|
2018
|
|
Biotechnology, Oncology, Molecular Diagnostics, Genomics
|
Bill Haack is the CEO of Cadex Genomics. To contact Bill Haack email at [email protected] or [email protected]. Or you may call 3202961801
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.